Tetanoz
Synopsis
Tetanus, whose history dates back to Egypt and derives its name from the Latin word for tension, is a potentially fatal infectious disease characterized by severe muscle spasms caused by the tetanospasmin neurotoxin produced by the bacterium Clostridium tetani. Although preventable through proper immunization methods, it continues to be observed with high mortality rates, particularly in developing countries with insufficient healthcare services and financial resources. While tetanolysin produced by anaerobic bacilli entering the body through disrupted skin integrity causes cell membrane damage, tetanospasmin travels retrogradely along motor neurons to reach the spinal cord and brainstem; by inhibiting the release of inhibitory neurotransmitters such as GABA and glycine, it leads to increased muscle tone, painful spasms, trismus (lockjaw), risus sardonicus, and autonomic instability. Tetanus, with an average incubation period of 8 days, is examined in four clinical forms: generalized, local, cephalic, and neonatal. Its diagnosis is established through patient history and clinical findings, and differential diagnosis is performed against conditions such as strychnine poisoning, drug-induced dystonias, and neuroleptic malignant syndrome. Its treatment is based on maintaining airway patency, stopping toxin production via wound debridement and antibiotic use, neutralizing unbound toxin with human tetanus immunoglobulin (HTIG), and controlling spasms and autonomic dysfunction using benzodiazepines and magnesium sulfate. In disease prevention, active immunization provided by vaccination alongside appropriate post-exposure wound care and prophylaxis are of vital importance.
References
Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, Parry CM. Neurological Aspects of Tropical Disease; Tetanus. J Neurol Neurosurg Psychiatry 2000; 69:292–301.
Bleck TP. Clostridium tetani (Tetanus). In: Mandel GL, Bennelt JE, Dolin R (eds) Principles and practice of infectious diseases, 6th ed. Churchill Livingstone, Philadelphia, 2005: 2817–2822.
Tekeli E. Tetanoz. Wilke Topçu A, Söyletir G, Doğanay M (eds). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. Nobel Tıp Kitapevleri, İstanbul, 2008; s. 1470-1476.
Atkinson W, Hamborsky J, McIntyre L, Wolfe S, Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. eds. 10th ed. Washington DC: Public Health Foundation, 2007.
Kıyan M. Clostridium türleri. Wilke Topçu A, Söyletir G, Doğanay M (eds). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. Nobel Tıp Kitapevleri, 2002; s. 1735-1747.
Torun MM. Clostridium cinsi. Kiraz N, Samastı M, Aygün G (eds). Mikrobiyoloji ve Klinik Mikrobiyoloji Ders Kitabı. İstanbul, 2011; s. 1074-1079.
Piscopo T, Azzopardi CM. Tetanus: forgiven, not forgotten. Malta Med J 2003; 16(4): 34-37.
Murray PR, Rosenthal KS, Pfaller MA. Başustaoğlu AC, Yıldıran ŞT, Tanyüksel M, Yapar M (eds). Clostridium tetani. Tıbbi Mikrobiyoloji, Altıncı baskı, 2010; s. 381-384.
Afshar M, Raju M, Ansell D, Bleck TP. Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med 2011; 154:329.
Centers for Disease Control and Prevention (CDC). Tetanus surveillance --- United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011; 60:365.
Yaffee AQ, Day DL, Bastin G, et al. Notes from the Field: Obstetric Tetanus in an Unvaccinated Woman After a Home Birth Delivery - Kentucky, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:307.
Kyu HH, Mumford JE, Stanaway JD, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health 2017; 17:179.
Tejpratap SP, Tiwari MD. Tetanus. In: Manual for the Surveillance of Vaccine-Preventable Diseases, 6th ed, Roush SW, Baldy LM (Eds), Centers for Disease Control and Prevention, Atlanta, GA 2008. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html (Accessed on April 22, 2016).
Collins S, Amirthalingam G, Beeching NJ, et al. Current epidemiology of tetanus in England, 2001-2014. Epidemiol Infect 2016; 144:3343.
Sakarya Tıp Dergisi 2020;10(2):303-306 ÇAMDAĞ ve Ark. Mültecide Tetanos
Cumhuriyet Tıp Dergisi Cumhuriyet Tıp Derg 2014; 36: 555-557 Olgu sunumu http://dx.doi.org/10.7197/1305-0028.2462)
UpToDate, Tetanus;Authors:Daniel J Sexton, MD Louise Thwaites,MD Section Editor:John G Bartlett, MD Deputy Editor:Jennifer Mitty, MD, MPH Literature review current through: Dec 2020. | This topic last updated: Apr 23, 2020.
Kıyan M. Anaerop, sporlu, gram pozitif basiller. Ustaçelebi S, Mutlu G, İmir T, Cengiz AT, Tümbay E, Mete Ö (eds). Temel ve Klinik Mikrobiyoloji. Güneş Kitabevi, Ankara, 1999; 624-632.
Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Tetanus. https://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html (Accessed on September 06, 2017).
Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet 2015; 385:362.
Doshi A, Warrell C, Dahdaleh D, Kullmann D. Just a graze? Cephalic tetanus presenting as a stroke mimic. Pract Neurol 2014; 14:39.
Weinstein L. Tetanus. N Engl J Med 1973; 289:1293.
Thwaites CL, Yen LM, Glover C, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health 2006; 11:279.
American Academy of Pediatrics. Tetanus (lockjaw). In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th, American Academy of Pediatrics, Elk Grove Village, IL 2009. p.655
Centers for Disease Control and Prevention. Tetanus - Wound Management.https://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html#medical (Accessed on February 24, 2020).
Miranda-Filho Dde B, Ximenes RA, Barone AA, et al. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ 2004; 328:615.
Lipman J, James MF, Erskine J, et al. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med 1987; 15:987.
Osalusi BS, Ogun SA, Ogunniyi A, Kolapo KO. Comparison of the efficacy of magnessium sulphate. Scientific Research and Essay 2008; 3:571.
Ali G, Kamal M, Khan AN. Comparison of the efficacy of magnesium sulphate and diazepam in the control of tetanus spasm. J Pak Med Assoc 2011; 25:106.
Buchanan N, Smit L, Cane RD, De Andrade M. Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J 1978; 2:254.
Trujillo MH, Castillo A, España J, et al. Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 1987; 92:63
Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet 2007; 370:1947.
Ceneviva GD, Thomas NJ, Kees-Folts D. Magnesium sulfate for control of muscle rigidity and spasms and avoidance of mechanical ventilation in pediatric tetanus. Pediatr Crit Care Med 2003; 4:480.
Patel JC, Mehta BC. Tetanus: study of 8,697 cases. Indian J Med Sci 1999; 53:393.
Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018; 67:1.
Havers FP, Moro PL, Hunter P, et al. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Morb Mortal Wkly Rep 2020; 69:77.
T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, Genişletilmiş Bağışıklama Programı Genelgesi, 2009.
T.C Sağlık Bakanlığı Aile Hekimliği uygulamasında önerilen periyodik sağlık muayeneleri ve tarama testleri 2015.
Rhee 2005, Türkiye Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Uzmanlık Derneği- Erişkin Bağışıklama Rehberi 2016.